News | ACC | October 08, 2019

American College of Cardiology Names Douglas Drachman Next Annual Scientific Session Vice Chair

Drachman will begin two-year term at ACC.21 followed by two years as meeting chair

American College of Cardiology Names Douglas Drachman Next Annual Scientific Session Vice Chair

Image courtesy of Massachusetts General Hospital


October 8, 2019 — Douglas Drachman, M.D., FACC, has been selected as the next vice chair of the American College of Cardiology’s (ACC) Annual Scientific Session. Drachman will serve as vice chair for ACC.21 and ACC.22 and transition to chair for ACC.23 and ACC.24.

Drachman is the Corrigan Minehan Heart Center Director of Education and the Teresa G. and Ferdinand F. Martignetti Endowed Chair for Cardiovascular Medicine at the Massachusetts General Hospital in Boston. His career has focused on education and advancing clinical care. He has been a member of the ACC Annual Scientific Session Program Committee since 2013 and has served on several education-focused ACC committees, including as chair of the Faculty Development Workgroup and the Curriculum Design Committee and as a member of the Lifelong Learning Oversight Committee.

Watch the VIDEO: Drug-coated Balloons Enter the U.S. Market, an interview with Drachman at ACC.15

In 2011, he participated in the ACC’s Emerging Faculty Program, which promotes skills development for emerging faculty who are committed to contributing to ACC’s education mission. At the completion of the program he was awarded the W. Proctor Harvey Teaching Award for his dedication and skill in teaching.

“Dr. Drachman has embodied ACC’s core value of promoting a culture of continuous improvement and lifelong learning,” said ACC president Richard J. Kovacs, M.D., FACC. “His skill and dedication to teaching and education are essential to leading the ACC’s Annual Scientific Session and ensuring we continue to host the premier cardiovascular conference in the world.”

Read the article “What Trends are Ahead in Cardiovascular Medicine in 2018?”

ACC established the role of vice chair in 2014 to ensure consistency and continual improvement of the ACC's flagship meeting. The Annual Scientific Session vice chair and chair are responsible for leading the development of the educational program, which attracts over 13,000 professional attendees to the meeting each year.

For more information: www.acc.org

Related Content

Feature | ACC | By Dave Fornell, Editor

Here are the top 10 takeaways from the late-breaking studies on cardiovascular technologies presented at the 2021 ...

Home June 08, 2021
Home
Feature | ACC | Dave Fornell, Editor

The latest cardiology practice-changing scientific breakthrough, late-breaking study presentations have been announced ...

Home May 18, 2021
Home
Feature | ACC

February 22, 2021 — The American College of Cardiology (ACC) moved its meeting from March to May 2021 in hopes that ...

Home February 22, 2021
Home
News | ACC | By Dave Fornell, Editor

UPDATE Feb 22, 2021 — ACC Abandons In-person Meeting and Goes Entirely Virtual for 2021 Due to COVID February 9, 2021 — ...

Home February 09, 2021
Home
Feature | ACC | Dave Fornell, Editor

Here is the list of American College of Cardiology (ACC) practice-changing late-breaking study presentations at the ACC ...

Home April 09, 2020
Home
Feature | ACC | Dave Fornell, Editor

March 9, 2020 — Less than week after the American College of Cardiology (ACC) said it would push ahead with holding its ...

Home March 09, 2020
Home
Feature | ACC | Greg Freiherr, Contributing Editor

The fingerprints of value-added medicine were all over products and works-in-progress on the exhibit floor of the annual ...

Home March 27, 2019
Home
Feature | ACC

The American College of Cardiology (ACC) released a list of the latest practice-changing presentations at the ACC.19 ...

Home March 19, 2019
Home
Feature | ACC | Dave Fornell

There were several notable presentations of new data on cardiovascular technologies at the recent 2018 American College ...

Home March 27, 2018
Home
News | ACC

March 22, 2018 — The experimental drug andexanet was associated with control of serious bleeding in patients taking a ...

Home March 22, 2018
Home
Subscribe Now